ZBTB38 and prostate carcinoma: Future studies, including additional patients, may yield more robust information regarding ZBTB38 mRNA association with prostate cancer aggressiveness, particularly in different ethnic populations or for patients with intermediate-risk (i.e., Gleason 7) prostate cancer.